Latest News
- Verasonics Celebrates 25 Years of Empowering Ultrasound Innovation - bastillepost.comon June 11, 2026 at 1:06 pm
Verasonics Celebrates 25 Years of Empowering Ultrasound Innovation bastillepost.com
- Verasonics Celebrates 25 Years of Empowering Ultrasound Innovation - Rutland Heraldon June 11, 2026 at 1:04 pm
Verasonics Celebrates 25 Years of Empowering Ultrasound Innovation Rutland Herald
- Verasonics Celebrates 25 Years of Empowering Ultrasound Innovation - Eagle-Tribuneon June 11, 2026 at 1:04 pm
Verasonics Celebrates 25 Years of Empowering Ultrasound Innovation Eagle-Tribune
- I Tried The Buzziest Zero-Downtime Treatment For Firmer Arms - The Zoe Reporton June 11, 2026 at 1:00 pm
I Tried The Buzziest Zero-Downtime Treatment For Firmer Arms The Zoe Report
- Ultrasound procedure for liver cancer keeps grandfather on transplant waiting list - Yahoo News Singaporeon June 11, 2026 at 12:20 pm
Ultrasound procedure for liver cancer keeps grandfather on transplant waiting list Yahoo News Singapore
- Real-time 3D ultrasound in augmented reality helps novices perform like expertson June 10, 2026 at 4:23 pm
Interpreting medical ultrasound images is a difficult task, requiring a technician to look at 2D images and mentally arrange them into a 3D representation of what the tissue looks like.
- Review explores impact of extreme endurance running on heart healthon June 10, 2026 at 6:18 am
Changes to the heart linked to marathon running vary by age, sex, and training level, finds a synthesis of the available data, published in the open access journal BMJ Open Sport & Exercise Medicine.
- Protein repair defects linked to hidden heart failureon June 9, 2026 at 5:33 am
Researchers in the del Monte Lab at the Medical University of South Carolina (MUSC) are the first to observe defects in the protein repair system associated with the peculiar, misfolded protein plaques previously observed in patients with idiopathic dilated cardiomyopathy (IDCM ).
- NYU Langone hits milestone with its 1,000th focal cryotherapy procedureon June 5, 2026 at 6:07 pm
Just two days after his minimally invasive prostate cancer treatment at NYU Langone Health, Broadway performer André De Shields, 80, was back onstage preparing for his next show, Cats: The Jellicle Ball, which debuted in April 2026.
- Three-drug strategy forces pancreatic tumors into lasting regressionon June 3, 2026 at 2:17 am
A triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression by blocking KRAS/RAS, EGFR/HER2, and STAT3 signaling. The approach prevented treatment resistance across mouse and human tumor-derived models, but remains preclinical and requires more clinically suitable drug combinations before human testing.